Sphingomyelinases in cell regulation

Seminars in Cell and Developmental Biology

Volumn 8, Issue 3, 1997, Pages 311-322

  Liu, Bin ^a   Obeid, Lina M ^a   Hannun, Yusuf A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cell regulation; Ceramide; Sphingomyelinase

Indexed keywords

EID: 0000993166     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1006/scdb.1997.0153     Document Type: Article

References (137)

1. Hannun YA, Loomis CR, Merrill AH, Jr, Bell RM (1986) Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and human platelets. J Biol Chem 261:12604-12609
2. 3 in HL-60 cells. Role in cell differentiation. J Biol Chem 264:19076-19080
3. Kim MY, Linardic C, Obeid L, Hannun Y (1991) Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem 266:484-489
4. Chatterjee S (1994) Neutral sphingomyelinase action stimulates signal transduction of tumor necrosis factor-a in the synthesis of cholesteryl esters in human fibroblasts. J Biol Chem 269:879-882
5. 2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 267:20044-20050
6. Mathias S, Younes A, Kan C-C, Orlow I, Joseph C, Kolesnick RN (1993) Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1b. Science 259:519-522
7. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA (1994) Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265:1596-1599
8. Ramachandran CK, Murray DK, Nelson DH (1990) Dexamethasone increases neutral sphingomyelinase activity and sphingosine levels in 3T3-L1 fibroblasts. Biochem Biophys Res Commun 167:607-613
9. Strum JC, Small GW, Pauig SB, Daniel LW (1994) 1-b-D-arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 269:15493-15497
10. Zhang J, Alter N, Reed JC, Borner C, Obeid LM, Hannun YA (1996) Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci USA 93:5325-5328
11. Jaffrézou J-P, Levade T, Bettaieb A, Andrieu N, Bezombes C, Maestre N, Vermeersch S, Rousse A, Laurent G (1996) Daunorubucin induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J 15:2417-2424
12. Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff RA, Yonehara S, Hannun YA, Seldin MF (1995) Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 92:8443-8447
13. Martin SJ, Newmeyer DD, Mathias S, Farschon DM, Wang HG, Reed JC, Kolesnick RN, Green DR (1995) Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J 14:5191-5200
14. Cifone MG, Roncaioli P, De Maria R, Camarda G, Santoni A, Ruberti G, Testi R (1995) Multiple pathways originate at the Fas/APO-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J 14:5859-5868
15. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R (1994) Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 180:1547-1552
16. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, Kolesnick RN (1994) Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180:525-535
17. Chang Y, Abe A, Shayman JA (1995) Ceramide formation during heat shock: A potential mediator of aB-crystallin transcription. Proc Natl Acad Sci USA 92:12275-12279
18. Venable ME, Lee JY, Smyth MJ, Bielawska A, Obeid LM (1995) Role of ceramide in cellular senescence. J Biol Chem 270:30701-30708
19. Jayadev S, Liu B, Bielawska AE, Lee JY, Nazaire F, Pushkareva MY, Obeid LM, Hannun YA (1995) Role for ceramide in cell cycle arrest. J Biol Chem 270:2047-2052
20. Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science 259:1769-1771
21. Dbaibo G, Pushkareva MY, Jayadev S, Schwartz JK, Horowitz JM, Obeid LM, Hannun YA (1995) Rb as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci USA 92:1347-1351
22. Smyth MJ, Perry DK, Zhang J, Poirier GG, Hannun YA, Obeid LM (1996) prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of bcl-2. Biochem J 316:25-28
23. Joseph CK, Byun H-S, Bittman R, Kolesnick RN (1993) Substrate recognition by ceramide-activated protein kinase. Evidence that kinase activity is proline-directed. J Biol Chem 268:20002-20006
24. Mathias S, Dressier KA, Kolesnick RN (1991) Characterization of a ceramide-activated protein kinase: Stimulation by tumor necrosis factor a. Proc Natl Acad Sci USA 88:10009-10013
25. Dobrowsky RT, Hannun YA (1992) Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem 267:5048-5051
26. Müller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K (1995) PKC zeta is a molecular switch in signal transduction of TNF-a, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14:1961-1969
27. Lozano J, Berra E, Municio MM, Diaz-Meco MT, Dominguez I, Sanz L, Moscat J (1994) Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J Biol Chem 269:19200-19202
28. Lee JY, Hannun YA, Obeid LM (1996) Ceramide inactivates cellular protein kinase Ca. J Biol Chem 271:13169-13174
29. Jones MJ, Murray AW (1995) Evidence that ceramide selectively inhibits protein kinase C-alpha translocation and modulates bradykinin activation of phospholipase D. J Biol Chem 270:5007-5013
30. Venable ME, Bielawska A, Obeid LM (1996) Ceramide inhibits phospholipase D in a cell-free system. J Biol Chem 271:24800-24805
31. Gomez-Munoz A, Martin A, O'Brien L, Brindley DN (1994) Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts. J Biol Chem 269:8937-8943
32. Sasaki T, Hazeki K, Hazeki O, Ui M, Katada T (1996) Focal adhesion kinase (p125FAK) and paxillin are substrates for sphingomyelinase-induced tyrosine phosphorylation in Swiss 3T3 fibroblasts. Biochem J 315:1035-1040
33. Chen CS, Rosenwald AG, Pagano RE (1995) Ceramide as a modulator of endocytosis. J Biol Chem 270:13291-13297
34. Wong K, Li XB, Hunchuk N (1995) N-acetylsphingosine (C2-ceramide) inhibited neutrophil superoxide formation and calcium influx. J Biol Chem 270:3056-3062
35. Richard A, Bourgoin S, Naccache PH, L'Heureux GP, Krump E, McColl SR, Pelletier G (1996) C2-ceramide primes specifically for the superoxide anion production induced by N-formylmethionylleucyl phenylalanine (fMLP) in human neutrophils. Biochim Biophys Acta 19:259-266
36. Westwick JK, Bielawska AE, Dbaibo G, Hannun YA, Brenner DA (1995) Ceramide activates the stress-activated protein kinases. J Biol Chem 270:22689-22692
37. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J Woodgett JR (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160
38. Laulederkind SJ, Bielawska A, Raghow R, Hannun YA, Ballou LR (1995) Ceramide induces interleukin 6 gene expression in human fibroblasts. J Exp Med 182:599-604
39. Fiebich BL, Lieb K, Berger M, Bauer J (1995) Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells. J Neuroimmunol 63:207-211
40. 2 and cyclooxygenase 2. Biochem Biophys Res Commun 220:681-686
41. Schneider PB, Kennedy EP (1967) Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J Lipid Res 8:202-209
42. Rao BG, Spence MW (1976) Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J Lipid Res 17:506-515
43. Yamaguchi S, Suzuki K (1977) Purification and characterization of sphingomyelinase from human brain. J Biol Chem 252:3805-3813
44. Maruyama EN, Arima M (1989) Purification and characterization of neutral and acid sphingomyelinases from rat brain. J Neurochem 52:611-618
45. Carre JB, Morand O, Homayoun P, Roux F, Bourre JM, Baumann N (1989) Purified rat brain microvessels exhibit both acid and neutral sphingomyelinase activities. J Neurochem 52:1294-1299
46. Nilsson A (1968) Metabolism of sphingomyelin in the intestinal tract of the rat. Biochimica et Biophysica Acta 164:575-584
47. Gatt S (1976) Magnesium-dependent sphingomyelinase. Biochem Biophys Res Commun 68:235-241
48. Hosteller KY, Yazaki PJ (1979) The subcellular localization of neutral sphingomyelinase in rat liver. J Lipid Res 20:456-463
49. Spence MW, Burgess JK, Sperker ER (1979) Neutral and acid sphingomyelinases: somatotopographical distribution in human brain and distribution in rat organs. A possible relationship with the dopamine system. Brain Res 168:543-551
50. Bartolf M, Franson RC (1986) Characterization and localization of neutral sphingomyelinase in bovine adrenal medulla. J Lipid Res 27:57-63
51. Chatterjee S, Ghosh N (1989) Neutral sphingomyelinase from human urine. Purification and preparation of monospecific antibodies. J Biol Chem 264:12554-12561
52. Vanha-Perttula T (1988) Sphingomyelinases in human, bovine and porcine seminal plasma. FEBS Lett 233:263-267
53. 3-induced HL-60 cell differentiation. J Biol Chem 269:4070-4077
54. Sperker ER, Spence MW (1983) Neutral and acid sphingomyelinases of rat brain: somatotopographical distribution and activity following experimental manipulation of the dopaminergic system in vivo. J Neurochem 40:1182-1184
55. Spence MW, Burgess JK (1978) Acid and neutral sphingomyelinases of rat brain. Activity in developing brain and regional distribution in adult brain. J Neurochem 30:917-919
56. Petkova DH, Momchilova-Pankova AB, Markovska TT, Koumanov KS (1988) Age-related changes in rat liver plasma membrane sphingomyelinase activity. Exp Geron 23:19-24
57. Spence MW, Wakkary J, Clarke JT, Cook HW (1982) Localization of neutral magnesium-stimulated sphingomyelinase in plasma membrane of cultured neuroblastoma cells. Biochim Biophys Acta 719:162-164
58. Das DV, Cook HW, Spence MW (1984) Evidence that neutral sphingomyelinase of cultured murine neuroblastoma cells is oriented externally on the plasma membrane. Biochim Biophys Acta 777:339-342
59. Linardic CM, Hannun YA (1994) Identification of a distinct pool of sphingomyelin involved in the sphingomyelin cycle. J Biol Chem 269:23530-23537
60. Andrieu N, Salvayre R, Levade T (1996) Comparative study of the metabolic pools of sphingomyelin and phosphatidylcholine sensitive to tumor necrosis factor. Eur J Biochem 236:738-745
61. Borchardt RA, Lee WT, Kalen A, Buckley RH, Peters C, Schiff S, Bell RM (1994) Growth-dependent regulation of cellular ceramides in human T-cells. Biochim Biophys Acta 1212:327-336
62. 2+-dependent, neutral sphingomyelinase in nuclei of rat ascites hepatoma cells. J Biochem (Tokyo) 106:593-598
63. Lister MD, Crawford-Redick CL, Loomis CR (1993) Characterization of the neutral pH-optimum sphingomyelinase from rat brain: Inhibition by copper II and ganglioside GM3. Biochim Biophys Acta Lipid Lipid Metab 1165:314-320
64. Tamiya-Koizumi K, Kojima K (1986) Activation of magnesium-dependent, neutral sphingomyelinase by phosphatidylserine. J Biochem (Tokyo) 99:1803-1806
65. Jayadev S, Linardic CM, Hannun YA (1994) Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor a. J Biol Chem 269:5757-5763
66. Yang Z, Costanzo M, Golde DW, Kolesnick RN (1993) Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells. J Biol Chem 268:20520-20523
67. Wiegmann K, Schütze S, Machleidt T, Witte D, Kronke M (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015
68. Jayadev S, Hayter H, Liu B, Hannun YA (1997) submitted
69. Coroneos E, Martinez M, McKenna S, Kester M (1995) Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines - Implications for cellular proliferation and differentiation. J Biol Chem 270:23305-23309
70. NTR with Trk receptors. J Biol Chem 270:22135-22142
71. Riboni L, Prinetti A, Bassi R, Caminiti A, Tettamanti G (1995) A mediator role of ceramide in the regulation of neuroblastoma Neuro2a cell differentiation. J Biol Chem 270:26868-26875
72. Ito A, Horigome K (1995) Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J Neurochem 65:463-466
73. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75-79
74. Chmura SJ, Nodzenski E, Weichselbaum RR, Quintans J (1996) Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res 56:2711-2714
75. Ghosh P, Chatterjee S (1987) Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells. J Biol Chem 262:12550-12556
76. Belka C, Wiegmann K, Adam D, Holland R, Neuloh M, Herrmann F, Krönke M, Brach MA (1995) Tumor necrosis factor (TNF)-a activates c-ra/1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J 14:1156-1165
77. Adam D, Wiegmann K, Adam-Klages S, Ruff A, Kronke M (1996) A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J Biol Chem 271:14617-14622
78. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, Kronke M (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86:937-947
79. Dbaibo GS, Perry DK, Gamard CJ, Platt R, Poirier GG, Obeid LM, Hannun YA (1997) CrmA inhibits ceramide formation in response to TNFalpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med 185:481-490
80. Pronk GJ, Ramer K, Amiri P, Williams LT (1996) Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271:808-810
81. Barnholz Y, Roitman A, Gatt S (1966) Enzymatic hydrolysis of sphingolipids > II. Hydrolysis of sphingomyelin by an enzyme from rat brain. J Biol Chem 241:3731-3737
82. Kanfer JN, Young OM, Shapiro D, Brady RO (1966) The metabolism of sphingomyelin. I. Purification and properties of a sphingomyelin-cleaving enzyme from rat liver tissue. J Biol Chem 241:1081-1084
83. Fowler S (1969) Lysosomal localization of sphingomyelinase in rat liver. Biochim Biophys Acta 191:481-484
84. Duncan R, Pratten MK (1977) Membrane economics in endocytic systems. J Theor Biol 66:727-735
85. Dean RT (1977) Lysosomes and membrane recycling. A hypothesis. Biochem J 168:603-605
86. Brady RO, Kanfer JN, Mock MN, Fredrickson DS (1966) The metabolism of sphingomyelin > II. Evidence of an enzymatic deficiency in Niemann-Pick disease. Proc Natl Acad Sci USA 55:366-369
87. Levran O, Desnick RJ, Schuchman EH (1991) Niemann-Pick disease: A frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients. Proc Natl Acad Sci USA 88:3748-3752
88. Levran O, Desnick RJ, Schuchman EH (1992) Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients. Blood 80:2081-2087
89. Takahashi T, Suchi M, Desnick RJ, Takada G, Schuchman EH (1992) Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. Molecular evidence for genetic heterogeneity in the neuronopathic and non-neuronopathic forms. J Biol Chem 267:12552-12558
90. Suchi M, Dinur T, Desnick RJ, Gatt S, Pereira L, Gilboa E Schuchman EH (1992) Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells. Proc Natl Acad Sci USA 89:3227-3231
91. Horinouchi K, Erlich S, Perl DP, Ferlinz K, Bisgaier CL, Sandhoff K, Desnick RJ, Stewart CL, Schuchman EH (1995) Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet 10:288-293
92. Otterbach B, Stoffel W (1995) Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81:1053-1061
93. Yamanaka T, Hanada E, Suzuki K (1981) Acid sphingomyelinase of human brain. Improved purification procedures and characterization. J Biol Chem 256:3884-3889
94. Yamanaka T, Suzuki K (1982) Acid sphingomyelinase of human brain: purification to homogeneity. J Neurochem 38:1753-1764
95. Pentchev PG, Brady RO, Gal AE, Hibbert SR (1977) The isolation and characterization of sphingomyelinase from human placental tissue. Biochim Biophys Acta 488:312-321
96. Kurth J, Stoffel W (1991) Human placental sphingomyelinase. Purification to homogeneity, antigenic properties and partial amino-acid sequences of the enzyme. Biol Chem Hoppe Seyler 372:215-223
97. Jones CS, Shankaran P, Callahan JW (1981) Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography. Biochem J 195:373-382
98. Sakuragawa N (1982) Acid sphingomyelinase of human placenta: purification, properties, and 125iodine labeling. J Biochem (Tokyo) 92:637-646
99. Watanabe K, Sakuragawa N, Arima M, Satoyoshi E (1983) Partial purification and properties of acid sphingomyelinase from rat liver. J Lipid Res 24:596-603
100. Quintern LE, Weitz G, Nehrkorn H, Tager JM, Schram AW, Sandhoff K (1987) Acid sphingomyelinase from human urine: purification and characterization. Biochim Biophys Acta 922:323-336
101. Ferlinz K, Hurwitz R, Weiler M, Suzuki K, Sandhoff K, Vanier MT (1995) Molecular analysis of the acid sphingomyelinase deficiency in a family with an intermediate form of Niemann-Pick disease. Am J Hum Genet 56:1343-1349
102. Quintern LE, Schuchman EH, Levran O, Suchi M, Ferlinz K, Reinke H, Sandhoff K, Desnick RJ (1989) Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J 8:2469-2473
103. Schuchman EH, Suchi M, Takahashi T, Sandhoff K, Kesnick RJ (1991) Human acid sphingomyelinase. Isolation, nucleotide sequence, and expression of the full-length and alternatively spliced cDNAs. J Biol Chem 266:8531-8539
104. Ida H, Rennert OM, Eto Y, Chan WY (1993) Cloning of a human acid sphingomyelinase cDNA with a new mutation that renders the enzyme inactive. J Biochem (Tokyo) 114:15-20
105. da Veiga Pereira L, Desnick RJ, Adler DA, Disteche CM, Schuchman EH (1991) Regional assignment of the human acid sphingomyelinase gene (SMPD1) by PCR analysis of somatic cell hybrids and in situ hybridization to 11p15. - 15.4. Genomics 9:229-234
106. Schuchman EH, Levran O, Pereira LV, Desnick RJ (1992) Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1). Genomics 12:197-205
107. Ferlinz K, Hurwitz R, Vielhaber G, Suzuki K, Sandhoff K (1994) Occurrence of two molecular forms of human acid sphingomyelinase. Biochem J 301:855-862
108. Hurwitz R, Ferlinz K, Vielhaber G, Moczall H, Sandhoff K (1994) Processing of human acid sphingomyelinase in normal and I-cell fibroblasts. J Biol Chem 269:5440-5445
109. Newrzella D, Stoffel W (1996) Functional analysis of the glycosylation of murine acid sphingomyelinase. J Biol Chem 271:32089-32095
110. Callahan JW, Gerrie J, Jones CS, Shankaran P (1981) Studies on the hydrophobic properties of sphingomyelinase. Biochem J 193:275-283
111. Quintern LE, Sandhoff K (1991) Human acid sphingomyelinase from human urine. Methods Enzymol 197:536-540
112. Levade T, Salvayre R, Douste-Blazy L (1983) Comparative hydrolysis of sphingomyelin and 2-N-(hexadecanoyl)-amino-4-nitrophenyl-phosphorylcholine by normal human brain homogenate at acid and neutral pH. J Neurochem 40:1762-1764
113. Klar R, Levade T, Gatt S (1988) Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease. Clin Chim Acta 176:259-267
114. Gal AE, Fash FJ (1976) Synthesis of a 2-n-(hexadecanoyl)-amino-4-nitrophenyl phosphorylcholine-hydroxide, a chromogenic substrate for assaying sphingomyelinase activity. Chem Phys Lipids 16:71-79
115. Alpert AJ, Beaudet AL (1981) Apolipoprotein C-III-1 activates lysosomal sphingomyelinase in vitro. J Clin Invest 68:1592-1596
116. Ahmad TY, Beaudet AL, Sparrow JT, Morrisett JD (1986) Human lysosomal sphingomyelinase: substrate efficacy of apolipoprotein/sphingomyelin complexes. Biochemistry 25:4415-4420
117. Morimoto S, Martin BM, Kishimoto Y, O'Brien JS (1988) Saposin D: a sphingomyelinase activator. Biochem Biophys Res Commun 156:403-410
118. Tayama M, Soeda S, Kishimoto Y, Martin BM, Callahan JW, Hiraiwa M, O'Brien JS (1993) Effect of saposins on acid sphingomyelinase. Biochem J 290:401-404
119. Ponting CP (1994) Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D. Protein Sci 3:359-361
120. Azuma N, O'Brien JS, Moser HW, Kishimoto Y (1994) Stimulation of acid ceramidase activity by saposin D. Arch Biochem Biophys 311:354-357
121. Yang Z, Costanzo M, Golde DW, Kolesnick RN (1993) Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappaB translocation in intact HL-60 cells. J Biol Chem 268:20520-20523
122. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M (1992) TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell 71:765-776
123. Andrieu N, Salvayre R, Levade T (1994) Evidence against involvement of the acid lysosomal sphingomyelinase in the tumour-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem J 303:341-345
124. Kuno K, Sukegawa K, Ishikawa Y, Orii T, Matsushima K (1994) Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NFkB activation. Int Immunol 6:1269-1272
125. Higuchi M, Singh S, Jaffrezou JP, Aggarwal BB (1996) Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappaB activation. J Immunol 157:297-304
126. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189-199
127. Boucher LM, Wiegmann K, Futterer A, Pfeffer K, Machleidt T, Schutze S, Mak TW, Kronke M (1995) CD28 signals through acidic sphingomyelinase [see comments]. J Exp Med 181:2059-2068
128. Chan G, Ochi A (1995) Sphingomyelin-ceramide turnover in CD28 costimulatory signaling. Eur J Immunol 25:1999-2004
129. Albouz S, Hauw JJ, Berwald-Netter Y, Boutry JM, Bourdon R, Baumann N (1981) Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures. Biomedicine 35:218-220
130. Albouz S, Vanier MT, Hauw JJ, Le Saux F, Boutry JM, Baumann N (1983) Effect of tricyclic antidepressants on sphingomyelinase and other sphingolipid hydrolases in C6 cultured glioma cells. Neurosci Lett 36:311-315
131. Hurwitz R, Ferlinz K, Sandhoff K (1994) The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol Chem Hoppe Seyler 375:447-450
132. Jaffrezou JP, Chen G, Duran GE, Muller C, Bordier C, Laurent G, Sikic BI, Levade T (1995) Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance. Biochim Biophys Acta 1266:1-8
133. Yamaguchi S, Suzuki K (1978) A novel magnesium-independent neutral sphingomyelinase associated with rat central nervous system meylin. J Biol Chem 253:4090-4092
134. 2+-stimulated sphingomyelinase in fetal bovine serum. J Biol Chem 264:5358-5363
135. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem 271:18431-18436
136. Nyberg L, Duan RD, Axelson J, Nilsson A (1996) Identification of an alkaline sphingomyelinase activity in human bile. Biochim Biophys Acta 1300:42-48
137. Duan RD, Nyberg L, Nilsson A (1995) Alkaline sphingomyelinase activity in rat gastrointestinal tract: distribution and characteristics. Biochim Biophys Acta 1259:49-55